Notes
Slide Show
Outline
1
Impact of Acoustic Non-Contact Transfer
Upon Compound Management and
Ultra High Throughput Screening
2
Automation at
Bristol-Myers Squibb
3
Current Platforms
  • CRS Rail systems
    • All compatible for 384 and low volume (LV) 384 well plates
    • Three systems 1536 well plate enabled
    • Polara scheduler operated
    • Peripheral equipment is virtually plug and play
4
384 and 1536-well
Screening
  • 384-well HTS is standard with some automated 1536-well screening
5
HTS Vs UHTS
WHY?
  • UHTS = >100K per screen/per system/per day
6
Fully Automated UHTS
Proof of Principal
  • Miniaturization works- Assay performance is similar to Std Vol 384
  • Pharmacology matches lower density plates
  • Current data from 1536-well FP assay at BMS
7
The Past to the Future
8
Flexible UHTS
  • Bringing it all together



9
Automated Systems
at BMS
10
Echo 550
11
Drop Formation
12
Droplet Ejection
13
 
14
1536-well Print
15
 
16
Acoustic Droplet Ejection
Benefits
  • Compound conservation
  • Disparate fill volumes acceptable
  • Auditing
    • Water content in DMSO via well auditing
    • Dropped well information
  • Cherry Picking
17
Acoustic Droplet Ejection
Cost Savings
18
Acoustic Droplet Ejection
Cost Savings-Cont.
19
Acoustic Droplet Ejection
Compound Conservation
  • Reutilize Source plates
  • Storage time-dependent on method so yet unrealized
  • Obviates the need for online store
    • In house developments or possibly Tekcel
  • Potentiates Closed-Loop UHTS
20
Where Do We Need
Solutions?
  • Source/Storage Plates Development
  • Speed of Echo Compound Cherry Picking
  • Online CRC dilution-Picoraptr?
  • Automated Storage and Retrieval
  • Automated Sealing and Unsealing Plates
  • Controlled Environment-Compound Storage?
  • Increased Flexibility in Scheduling
  • Must Be Seamless with Compound Management-1536 source filling and tracking



21
Definitive Impact
  • UHTS capability
  • Cost advantage due to miniaturization, consumables and waste management
  • Auditing feedback
  • Compound conservation
  • Hit picking capability
  • Decreased systematic error-↑Accuracy & Precision
  • **Sweeping changes to current compound supply line (compounds are reformatted at the time of the assay vs. pre-plating or aqueous dilution.)




22
Future Endeavors
  • Implementing more Echo 550s


  • Co-developing an optimum source plate


  • Online storage and retrieval


  • Closed loop screening


23
 
24
Acknowledgements
  • Bristol-Myers Squibb
  • Martyn Banks
  • Alastair Binnie
  • Jonathan O’Connell
  • Yvonne Fitzgerald
  • Jim Myslik
  • Mark Gilchrist
  • Kim Marmora
  • Jennifer Zewinski
  • Normand Cloutier
  • Ben Carvalho
  • Joe Yacobucci
  • Dan Maloney
  • Neil Burford
  • David Harden
  • Angela Cacace
  • Tatyana Zvyaga
  • Jason Ansaldo
  • Moneesh Chatterjee
  • Sandra Matson